57/100B423.40
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+5%262Price 423.40501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health net income 1998–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Elevance Health earned 1.37B USD in Q3 FY2026, the three months to 30 September 2026, up 14.8% on the same quarter a year before. Elevance Health's net income over the last twelve months was 5.14B USD, down 7.1% on the twelve months before. In fiscal year 2025 it earned 5.66B USD, down 5.3% on the year before.
Last updated 12 Nov 2026 · Next report 27 Jan 2027
Net income
Net income · +8.3% a year over 10 yearsNet margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 5.14B | -7.12% | 2.55% | 201.83B |
| FY2025 | 31 Dec 2025 | 5.66B | -5.32% | 2.84% | 199.13B |
| FY2024 | 31 Dec 2024 | 5.98B | -0.12% | 3.38% | 176.81B |
| FY2023 | 31 Dec 2023 | 5.99B | +1.58% | 3.49% | 171.34B |
| FY2022 | 31 Dec 2022 | 5.89B | -3.44% | 3.76% | 156.60B |
| FY2021 | 31 Dec 2021 | 6.10B | +33.51% | 4.40% | 138.64B |
| FY2020 | 31 Dec 2020 | 4.57B | -4.89% | 3.75% | 121.87B |
| FY2019 | 31 Dec 2019 | 4.81B | +28.19% | 4.61% | 104.21B |
| FY2018 | 31 Dec 2018 | 3.75B | -2.41% | 4.07% | 92.11B |
| FY2017 | 31 Dec 2017 | 3.84B | +55.59% | 4.27% | 90.04B |
| FY2016 | 31 Dec 2016 | 2.47B | -3.52% | 2.91% | 84.98B |
| FY2015 | 31 Dec 2015 | 2.56B | -0.38% | 3.23% | 79.24B |
| FY2014 | 31 Dec 2014 | 2.57B | -3.18% | 3.48% | 73.92B |
| FY2013 | 31 Dec 2013 | 2.65B | -0.05% | 3.73% | 71.12B |
| FY2012 | 31 Dec 2012 | 2.66B | +0.33% | 4.32% | 61.54B |
| FY2011 | 31 Dec 2011 | 2.65B | -8.33% | 4.35% | 60.80B |
| FY2010 | 31 Dec 2010 | 2.89B | -39.17% | 4.91% | 58.84B |
| FY2009 | 31 Dec 2009 | 4.75B | +90.54% | 7.70% | 61.64B |
| FY2008 | 31 Dec 2008 | 2.49B | -25.55% | 3.99% | 62.46B |
| FY2007 | 31 Dec 2007 | 3.35B | +8.09% | 5.45% | 61.39B |
| FY2006 | 31 Dec 2006 | 3.09B | +25.61% | 5.43% | 57.01B |
| FY2005 | 31 Dec 2005 | 2.46B | +156.62% | 5.46% | 45.15B |
| FY2004 | 31 Dec 2004 | 960.10M | +24.00% | 4.61% | 20.82B |
| FY2003 | 31 Dec 2003 | 774.30M | +41.01% | 4.62% | 16.75B |
| FY2002 | 31 Dec 2002 | 549.10M | +60.46% | 4.14% | 13.26B |
| FY2001 | 31 Dec 2001 | 342.20M | +51.42% | 3.28% | 10.44B |
| FY2000 | 31 Dec 2000 | 226.00M | +403.34% | 1.31% | 17.31B |
| FY1999 | 31 Dec 1999 | 44.90M | -73.96% | 0.36% | 12.35B |
| FY1998 | 31 Dec 1998 | 172.40M | — | 1.56% | 11.07B |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.37B | +14.80% | 2.65% | 51.43B |
| Q2 FY2026 | 30 Jun 2026 | 1.46B | -16.06% | 2.90% | 50.47B |
| Q1 FY2026 | 31 Mar 2026 | 1.76B | -19.19% | 3.52% | 50.18B |
| Q4 FY2025 | 31 Dec 2025 | 547.00M | +30.86% | 1.10% | 49.75B |
| Q3 FY2025 | 30 Sept 2025 | 1.19B | +17.03% | 2.34% | 50.71B |
| Q2 FY2025 | 30 Jun 2025 | 1.74B | -24.22% | 3.50% | 49.78B |
| Q1 FY2025 | 31 Mar 2025 | 2.18B | -2.80% | 4.47% | 48.89B |
| Q4 FY2024 | 31 Dec 2024 | 418.00M | -51.17% | 0.92% | 45.44B |
| Q3 FY2024 | 30 Sept 2024 | 1.02B | -21.18% | 2.25% | 45.15B |
| Q2 FY2024 | 30 Jun 2024 | 2.30B | +24.12% | 5.27% | 43.65B |
| Q1 FY2024 | 31 Mar 2024 | 2.25B | +12.92% | 5.28% | 42.58B |
| Q4 FY2023 | 31 Dec 2023 | 856.00M | -1.04% | 2.01% | 42.65B |
| Q3 FY2023 | 30 Sept 2023 | 1.29B | -19.59% | 3.01% | 42.85B |
| Q2 FY2023 | 30 Jun 2023 | 1.85B | +13.19% | 4.24% | 43.67B |
| Q1 FY2023 | 31 Mar 2023 | 1.99B | +11.18% | 4.72% | 42.17B |
| Q4 FY2022 | 31 Dec 2022 | 865.00M | -23.92% | 2.17% | 39.93B |
| Q3 FY2022 | 30 Sept 2022 | 1.60B | +6.23% | 4.01% | 39.94B |
| Q2 FY2022 | 30 Jun 2022 | 1.64B | -8.70% | 4.24% | 38.63B |
| Q1 FY2022 | 31 Mar 2022 | 1.79B | +7.45% | 4.70% | 38.10B |
| Q4 FY2021 | 31 Dec 2021 | 1.14B | +106.35% | 3.11% | 36.58B |
| Q3 FY2021 | 30 Sept 2021 | 1.51B | +579.73% | 4.21% | 35.82B |
| Q2 FY2021 | 30 Jun 2021 | 1.79B | -21.22% | 5.30% | 33.85B |
| Q1 FY2021 | 31 Mar 2021 | 1.67B | +9.32% | 5.14% | 32.39B |
| Q4 FY2020 | 31 Dec 2020 | 551.00M | -41.01% | 1.73% | 31.82B |
| Q3 FY2020 | 30 Sept 2020 | 222.00M | -81.23% | 0.71% | 31.16B |
| Q2 FY2020 | 30 Jun 2020 | 2.28B | +99.82% | 7.78% | 29.26B |
| Q1 FY2020 | 31 Mar 2020 | 1.52B | -1.81% | 5.14% | 29.62B |
| Q4 FY2019 | 31 Dec 2019 | 934.00M | +119.76% | 3.41% | 27.41B |
| Q3 FY2019 | 30 Sept 2019 | 1.18B | +23.23% | 4.44% | 26.67B |
| Q2 FY2019 | 30 Jun 2019 | 1.14B | +8.13% | 4.47% | 25.47B |
| Q1 FY2019 | 31 Mar 2019 | 1.55B | +18.17% | 6.29% | 24.67B |
| Q4 FY2018 | 31 Dec 2018 | 425.00M | -65.47% | 1.82% | 23.37B |
| Q3 FY2018 | 30 Sept 2018 | 960.00M | +28.53% | 4.13% | 23.25B |
| Q2 FY2018 | 30 Jun 2018 | 1.05B | +23.16% | 4.59% | 22.94B |
| Q1 FY2018 | 31 Mar 2018 | 1.31B | +29.96% | 5.82% | 22.54B |
| Q4 FY2017 | 31 Dec 2017 | 1.23B | +234.07% | 5.43% | 22.68B |
| Q3 FY2017 | 30 Sept 2017 | 746.90M | +20.90% | 3.33% | 22.43B |
| Q2 FY2017 | 30 Jun 2017 | 855.30M | +9.57% | 3.82% | 22.41B |
| Q1 FY2017 | 31 Mar 2017 | 1.01B | +43.66% | 4.48% | 22.53B |
| Q4 FY2016 | 31 Dec 2016 | 368.40M | +103.65% | 1.70% | 21.73B |
| Q3 FY2016 | 30 Sept 2016 | 617.80M | -5.65% | 2.88% | 21.41B |
| Q2 FY2016 | 30 Jun 2016 | 780.60M | -9.14% | 3.64% | 21.46B |
| Q1 FY2016 | 31 Mar 2016 | 703.00M | -18.75% | 3.47% | 20.29B |
| Q4 FY2015 | 31 Dec 2015 | 180.90M | -64.30% | 0.90% | 20.19B |
| Q3 FY2015 | 30 Sept 2015 | 654.80M | +3.79% | 3.29% | 19.90B |
| Q2 FY2015 | 30 Jun 2015 | 859.10M | +17.51% | 4.29% | 20.02B |
| Q1 FY2015 | 31 Mar 2015 | 865.20M | +23.42% | 4.54% | 19.05B |
| Q4 FY2014 | 31 Dec 2014 | 506.70M | +241.90% | 2.67% | 18.98B |
| Q3 FY2014 | 30 Sept 2014 | 630.90M | -3.86% | 3.40% | 18.56B |
| Q2 FY2014 | 30 Jun 2014 | 731.10M | -8.62% | 3.96% | 18.47B |
| Q1 FY2014 | 31 Mar 2014 | 701.00M | -20.81% | 3.93% | 17.86B |
| Q4 FY2013 | 31 Dec 2013 | 148.20M | -68.07% | 0.84% | 17.57B |
| Q3 FY2013 | 30 Sept 2013 | 656.20M | -5.06% | 3.68% | 17.86B |
| Q2 FY2013 | 30 Jun 2013 | 800.10M | +24.32% | 4.52% | 17.69B |
| Q1 FY2013 | 31 Mar 2013 | 885.20M | +3.35% | 5.04% | 17.58B |
| Q4 FY2012 | 31 Dec 2012 | 464.20M | +38.44% | 2.99% | 15.54B |
| Q3 FY2012 | 30 Sept 2012 | 691.20M | +1.17% | 4.50% | 15.35B |
| Q2 FY2012 | 30 Jun 2012 | 643.60M | -8.27% | 4.18% | 15.41B |
| Q1 FY2012 | 31 Mar 2012 | 856.50M | -7.57% | 5.56% | 15.42B |
| Q4 FY2011 | 31 Dec 2011 | 335.30M | -38.90% | 2.19% | 15.32B |
| Q3 FY2011 | 30 Sept 2011 | 683.20M | -7.56% | 4.44% | 15.40B |
| Q2 FY2011 | 30 Jun 2011 | 701.60M | -2.88% | 4.65% | 15.10B |
| Q1 FY2011 | 31 Mar 2011 | 926.60M | +5.68% | 6.22% | 14.89B |
| Q4 FY2010 | 31 Dec 2010 | 548.80M | -79.98% | 3.75% | 14.65B |
| Q3 FY2010 | 30 Sept 2010 | 739.10M | +1.22% | 5.07% | 14.57B |
| Q2 FY2010 | 30 Jun 2010 | 722.40M | +4.17% | 5.01% | 14.43B |
| Q1 FY2010 | 31 Mar 2010 | 876.80M | +51.07% | 5.82% | 15.07B |
| Q4 FY2009 | 31 Dec 2009 | 2.74B | +727.34% | 14.40% | 19.05B |
| Q3 FY2009 | 30 Sept 2009 | 730.20M | -11.03% | 4.73% | 15.43B |
| Q2 FY2009 | 30 Jun 2009 | 693.50M | -7.59% | 4.50% | 15.41B |
| Q1 FY2009 | 31 Mar 2009 | 580.40M | -1.31% | 3.83% | 15.14B |
| Q4 FY2008 | 31 Dec 2008 | 331.40M | -61.42% | 2.20% | 15.07B |
| Q3 FY2008 | 30 Sept 2008 | 820.70M | -5.45% | 5.49% | 14.96B |
| Q2 FY2008 | 30 Jun 2008 | 750.50M | -10.14% | 4.79% | 15.67B |
| Q1 FY2008 | 31 Mar 2008 | 588.10M | -24.90% | 3.78% | 15.55B |
| Q4 FY2007 | 31 Dec 2007 | 859.10M | +7.24% | 5.52% | 15.56B |
| Q3 FY2007 | 30 Sept 2007 | 868.00M | +7.05% | 5.69% | 15.24B |
| Q2 FY2007 | 30 Jun 2007 | 835.20M | +11.18% | 5.47% | 15.27B |
| Q1 FY2007 | 31 Mar 2007 | 783.10M | +7.01% | 5.19% | 15.09B |
| Q4 FY2006 | 31 Dec 2006 | 801.10M | +22.87% | 5.50% | 14.56B |
| Q3 FY2006 | 30 Sept 2006 | 810.80M | +26.55% | 5.61% | 14.45B |
| Q2 FY2006 | 30 Jun 2006 | 751.20M | +34.29% | 5.30% | 14.17B |
| Q1 FY2006 | 31 Mar 2006 | 731.80M | +19.63% | 5.29% | 13.84B |
| Q4 FY2005 | 31 Dec 2005 | 652.00M | +253.39% | 5.70% | 11.43B |
| Q3 FY2005 | 30 Sept 2005 | 640.70M | +164.64% | 5.74% | 11.16B |
| Q2 FY2005 | 30 Jun 2005 | 559.40M | +135.14% | 5.02% | 11.15B |
| Q1 FY2005 | 31 Mar 2005 | 611.70M | +106.94% | 5.59% | 10.94B |
| Q4 FY2004 | 31 Dec 2004 | 184.50M | -11.64% | 2.70% | 6.83B |
| Q3 FY2004 | 30 Sept 2004 | 242.10M | +23.21% | 5.04% | 4.81B |
| Q2 FY2004 | 30 Jun 2004 | 237.90M | +34.18% | 5.16% | 4.61B |
| Q1 FY2004 | 31 Mar 2004 | 295.60M | +54.20% | 6.46% | 4.57B |
| Q4 FY2003 | 31 Dec 2003 | 208.80M | +21.47% | 4.86% | 4.29B |
| Q3 FY2003 | 30 Sept 2003 | 196.50M | +14.78% | 4.61% | 4.26B |
| Q2 FY2003 | 30 Jun 2003 | 177.30M | +66.95% | 4.31% | 4.11B |
| Q1 FY2003 | 31 Mar 2003 | 191.70M | +92.08% | 4.68% | 4.10B |
| Q4 FY2002 | 31 Dec 2002 | 171.90M | +96.01% | 4.31% | 3.99B |
| Q3 FY2002 | 30 Sept 2002 | 171.20M | +53.54% | 4.78% | 3.58B |
| Q2 FY2002 | 30 Jun 2002 | 106.20M | — | 3.66% | 2.90B |
| Q1 FY2002 | 31 Mar 2002 | 99.80M | -83.03% | 3.55% | 2.81B |
| Q4 FY2001 | 31 Dec 2001 | 87.70M | — | 3.29% | 2.66B |
| Q3 FY2001 | 30 Sept 2001 | 111.50M | — | 4.19% | 2.66B |
| Q1 FY2001 | 31 Mar 2001 | 588.10M | — | 3.78% | 15.55B |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Elevance Health's profit
Source: Financial Modeling Prep